Table 1.

Patient demographic and clinical characteristics at time of surgery.

Variable	Overall (N = 112)	PCA (N = 44)	TAP (N = 30)	PCEA (N = 38)	P-value
	n (%)	n (%)	n (%)	n (%)
Narcotic use prior to surgery					0.192
No	89 (79.5)	31 (70.5)	26 (86.7)	32 (84.2)
Yes	23 (20.5)	13 (29.6)	4 (13.3)	6 (15.8)
Diabetes					0.865
No	90 (81.1)	36 (81.8)	25 (83.3)	29 (78.4)
Yes	21 (18.9)	8 (18.2)	5 (16.7)	8 (21.6)
Missing	1(0.9)	0 (0.0)	0 (0.0)	1 (2.6)
Hypertension					0.018
No	55 (49.6)	15 (34.1)	20 (66.7)	20 (54.1)
Yes	56 (50.5)	29 (65.9)	10 (33.3)	17 (46.0)
Missing	1 (0.9)	0 (0.0)	0 (0.0)	1 (2.6)
Obstructive sleep apnea					0.520
No	106 (95.5)	43 (97.7)	29 (96.7)	34 (91.9)
Yes	5 (4.5)	1 (2.3)	1 (3.3)	3 (8.1)
Missing	1 (0.9)	0 (0.0)	0 (0.0)	1 (2.6)
Type of Surgerya					0.190
<TAH	11 (9.8)	5 (11.4)	5 (16.7)	1 (2.6)
TAH	17 (15.2)	6 (13.6)	5 (16.7)	6 (15.8)
Debulking	77 (68.8)	31 (70.5)	16 (53.3)	30 (79.0)
Bowel surgery	7 (6.3)	2 (4.6)	4 (13.3)	1 (2.6)
Disease type					0.699
Benign	28 (25.0)	11 (25.0)	9 (30.0)	8 (21.1)
Malignant	84 (75.0)	33 (75.0)	21 (70.0)	30 (79.0)
Lymph node dissection					0.478
No	80 (71.4)	30 (68.2)	24 (80.0)	26 (68.4)
Yes	32 (28.6)	14 (31.8)	6 (20.0)	12 (31.6)
	Mean (SD)	Mean (SD)	Mean (SD)	Mean (SD)
Age	57.8 (14.2)	59.1 (12.4)	53.9 (16.3)	59.5 (14.1)	0.201
BMI	30.4 (8.6)	31.3 (10.0)	30.1 (6.5)	29.6 (8.7)	0.652

The bold show the significant results. The italicized data reflect missing data.

1) <TAH: No hysterectomy or debulking.

2) TAH: Hysterectomy +/− adnexal procedure.

3) Debulking: Any staging (omentectomy, lymph node dissection, peritoneal biopsies) or tumor debulking beyond hysterectomy/salpingo-oophorectomy, excluding bowel surgery.

4) Bowel surgery: Any small or large bowel procedure.

^aPatients were categorized into 4 groups based on type of surgery.